Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Evidence against presynaptic α-adrenoreceptor modulation of cardiac sympathetic transmission

Abstract

In addition to its well known actions on postsynaptic adrenoreceptors, noradrenaline released at the sympathetic nerve endings is now believed to modulate subsequent transmitter release through its actions on presynaptic receptors1–7. Much evidence in support of this hypothesis has been obtained from overflow studies in which labelled noradrenaline and metabolites released into the bathing solution are used as an assay of transmitter release. According to Langer4 and Rand, McCulloch and Story6, evidence to favour the existence of such a presynaptic mechanism includes the demonstration that α-adrenoreceptor antagonists produce enhanced transmitter overflow in steady-state conditions of sympathetic stimulation. They also suggest that α-adrenoreceptor-mediated potentiation of transmitter release would not be expected in response to a single pulse, as a threshold concentration of released noradrenaline is required to activate presynaptic inhibition of further release. In the myocardium both conditions have been obtained in the presence of phenoxybenzamine5,6. Surprisingly, although phentolamine is also a potent α-adrenoreceptor antagonist, the potentiation of transmitter release was less than the increase due to phenoxybenzamine6. Studies of transmitter overflow have generally been made with supraphysiological sympathetic stimulation of 5 Hz continuously for 30s or 4 Hz for 60s (refs 6,7). We have used more closely physiological stimulation parameters delivered only during the atrial refractory period. We have now shown that phenoxybenzamine markedly potentiates the chronotropic response to a single pulse and also responses up to maximum stimuli. By contrast, phentolamine and yohimbine were totally without effect even at high concentration. The action of phenoxybenzamine was largely accounted for by its effect on uptake blockade. Taken together, our studies provide evidence against a physiological role of presynaptic α-adrenoreceptors in the heart

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Farnebo, L. O. & Hamberger, B. Br. J. Pharmac. 43, 97–106 (1971).

    Article  CAS  Google Scholar 

  2. Enero, M. A., Langer, S. Z., Rothlin, R. P. & Stefano, F. J. E. Br. J. Pharmac. 44, 672–688 (1972).

    Article  CAS  Google Scholar 

  3. Starke, K. Naunyn-Schmiedebergs Archs Pharmak. 275, 11–23 (1972).

    Article  CAS  Google Scholar 

  4. Langer, S. Z. Br. J. Pharmac. 60, 481–497 (1977).

    Article  CAS  Google Scholar 

  5. Rand, M. J., Story, D. F., Allen, G. S., Glover, B. & McCulloch, M. W. in Frontiers in Catecholamine Research (eds Usdin, E. & Synder, S. H.) 579–581 (Pergamon, Oxford, 1973).

    Book  Google Scholar 

  6. Rand, M. J., McCulloch, M. W. & Story, D. F. in Central Action of Drugs in Blood Pressure Regulation (eds Davies, D. S. & Reid, J. L.) 94–132 (Pitman, Tunbridge Wells, 1975).

    Google Scholar 

  7. Langer, S. Z., Adler-Graschinsky, E. & Giorgi, O. Nature 265, 648–650 (1977).

    Article  ADS  CAS  Google Scholar 

  8. Blinks, J. R. J. Pharmac. exp. Ther. 151, 221–235 (1966).

    CAS  Google Scholar 

  9. Paton, D. M. in The Mechanism of Neuronal and Extraneuronal Transport of Calecholamines (ed. Paton, D. M.) 49–66 (Raven, New York, 1976).

    Google Scholar 

  10. Iversen, L. L. The Uptake and Storage of Noradrenaline in Sympathetic Nerves (Cambridge University Press, 1967).

    Google Scholar 

  11. Starke, K., Borowski, E. & Endo, T. Eur. J. Pharmac. 34, 385–388 (1975).

    Article  CAS  Google Scholar 

  12. Lockhandwala, M. F. & Buckley, J. P. Eur. J. Pharmac. 40, 183–186 (1976).

    Article  Google Scholar 

  13. Cavero, I. et al. Br. J. Pharmac. 67, 283–292 (1979).

    Article  CAS  Google Scholar 

  14. Mouillé, P., Huchet, A-M., Lucet, B., Chelly, J. & Schmitt, H. J. cardiovascular Pharmac. 1, 515–528 (1979).

    Article  Google Scholar 

  15. Docherty, J. P. & McGrath, J. C. Br. J. Pharmac. 66, 55–63 (1979).

    Article  CAS  Google Scholar 

  16. Iversen, L. L. Adv. Drug. Res. 2, 5–23 (1965).

    Google Scholar 

  17. Story, D. F., Story, M. E., McCulloch, M. W., Hope, W. & Rand, M. J. Clin. exp. Physiol. Pharmac. 1, 429–439 (1974).

    Article  CAS  Google Scholar 

  18. Salt, P. J. Eur. J. Pharmac. 20, 329–340 (1972).

    Article  CAS  Google Scholar 

  19. Trendelenberg, U. Trends pharmac. Sci. 1, 4–6 (1979).

    Article  Google Scholar 

  20. Adler-Graschinsky, E. & Langer, S. Z. Br. J. Pharmac. 53, 43–50 (1975).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Angus, J., Korner, P. Evidence against presynaptic α-adrenoreceptor modulation of cardiac sympathetic transmission. Nature 286, 288–291 (1980). https://doi.org/10.1038/286288a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/286288a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing